Trademarkia Logo

Australia

AU$
KYDVIA
Cancelled: Cancelled at the request of IB

Last updated on 1 Nov 2022

Owner Info

QUARK PHARMACEUTICALS, INC.

Suite 310,

7999 Gateway Boulevard, UNITED STATES OF AMERICA

Serial Number

2047745 filed on 12 Sept 2019

Correspondent

Michael D. Hammer JMB DAVIS BEN-DAVID

8 HARTOM STREET,,

PO BOX 45087,

ISRAEL

KYDVIA

Classification Information


Class [005]
Pharmaceutical compositions for the treatment of disorders of the kidney; pharmaceutical compositions for the treatment of disorders of the kidney ass Read More

Mark Details


Serial Number

2047745

Registered On

12 Sept 2019

Renewal On

NA

Mark Type

WORD

Priority Claim (Convention Details)


Date

4 Sept 2019

Mark Type

US

Legal History


Show more

Status DateAction Taken
1st Nov 2022Status change to Voided
16th Apr 2020International Registration in Australia Protected correspondence sent
15th Apr 2020IP Right Registration Published
15th Apr 2020Status change to Registered/Protected
5th Feb 2020Application Accepted correspondence sent
5th Feb 2020IP Right has been Examined
5th Feb 2020IP Right Acceptance Published
13th Jan 2020Status change to Accepted
31st Oct 2019Awaiting examination
31st Oct 2019Examination expedited